Click a link below to view the mailing archive as if it had been sent to you.
| 2019-06-30 00:15 | | Where Will Cara Therapeutics Be in 5 Years? and more... |
| 2019-06-29 00:15 | | ‘Product hopping’ under fire in Senate bill and more... |
| 2019-06-28 12:15 | | The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far) and more... |
| 2019-06-28 00:15 | | Lilly's Study on Higher Doses of Trulicity Meets Endpoint and more... |
| 2019-06-27 12:15 | | U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached? and more... |
| 2019-06-27 00:15 | | CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs and more... |
| 2019-06-26 12:15 | | Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch and more... |
| 2019-06-26 00:15 | | Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX? and more... |
| 2019-06-25 12:15 | | Pharma's got its chief digital officers. Now let's see results: Sanofi executive and more... |
| 2019-06-25 00:15 | | FDA Action Alert: Regeneron, Sanofi, Celgene and more... |
| 2019-06-24 12:15 | | Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia and more... |
| 2019-06-24 00:15 | | The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs |
| 2019-06-23 22:07 | | CP Microbiome Report wk ending 6-23-19 |
| 2019-06-23 00:15 | | FDA proposes comparative approval standards for new opioids and more... |
| 2019-06-22 00:15 | | FDA declines to approve Daiichi Sankyo's blood cancer treatment and more... |
| 2019-06-21 12:15 | | 3 Drugs Under FDA Review With Blockbuster Potential and more... |
| 2019-06-21 00:15 | | Strength of Oncology Pipeline Touted at Merck’s First Investor Day in Five Years and more... |
| 2019-06-20 12:15 | | Four More Through the IPO Door as Life Science Firms Raise $465M and more... |
| 2019-06-20 00:15 | | Researchers ID 14 Genes Linked to Survival in Pediatric Liver Disease and more... |
| 2019-06-19 12:15 | | Vaccines mistrust a “global crisis” says Wellcome report and more... |
| 2019-06-19 00:15 | | Meet the Top Ten Drugs of 2024 (Maybe) and more... |
| 2019-06-18 12:15 | | Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks and more... |
| 2019-06-18 00:15 | | Boehringer Ingelheim opens inhaler plant with 200 jobs and more... |
| 2019-06-17 12:15 | | Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist and more... |
| 2019-06-17 00:15 | | Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report and more... |
| 2019-06-16 00:15 | | June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more and more... |
| 2019-06-15 00:15 | | Research Roundup: A New Protein Linked to Alzheimer’s and Other Highlights and more... |
| 2019-06-14 12:15 | | More Medical Mega-Breaches Thanks To Third-Party Insecurity and more... |
| 2019-06-14 00:15 | | FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin and more... |
| 2019-06-13 12:15 | | Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal and more... |
| 2019-06-13 00:15 | | Judge holds up Teva's $85M opioid settlement, sinking shares back to pre-2000 levels and more... |
| 2019-06-12 12:15 | | Sobi to buy Novimmune R&D assets, lay off 90 staff and more... |
| 2019-06-12 00:15 | | DeSantis signs Florida drug importation bill and more... |
| 2019-06-11 12:15 | | CymaBay Therapeutics Stumbles in NASH Race, Shares Fall and more... |
| 2019-06-11 00:15 | | Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout and more... |
| 2019-06-10 12:15 | | The top 20 highest-paid biopharma CEOs of 2018 and more... |
| 2019-06-10 00:15 | | BIO Roundup: Agenus, FDA, Merck’s Frazier and Much More and more... |
| 2019-06-09 00:15 | | Genetic testing: the next big arena for fraud? and more... |
| 2019-06-08 12:15 | | Chipscreen set to test Shanghai’s new innovation board |
| 2019-06-08 00:15 | | FDA's Draft Guidance Proposes Ways to Increase Patient Diversity in Clinical Trials and more... |
| 2019-06-07 12:15 | | Vertex sets sights on DMD gene therapy, joining crowded field and more... |
| 2019-06-07 00:15 | | A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report and more... |
| 2019-06-06 12:15 | | AstraZeneca ends another Calquence trial early and more... |
| 2019-06-06 00:15 | | Mallinckrodt hit with new kickback charges same day as $15.4M settlement with the feds and more... |
| 2019-06-05 12:15 | | ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More and more... |
| 2019-06-05 00:15 | | Leaders Weigh In: How to Combat the Diversity Divide in Biotech and more... |
| 2019-06-04 12:15 | | Bayer inks Arvinas deal to develop protein degraders and more... |
| 2019-06-04 00:15 | | Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein? and more... |
| 2019-06-03 12:15 | | ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR and more... |
| 2019-06-03 00:15 | | Research Ayala's ex-BMS drug shows promise in triple-negative breast cancer and more... |
| 2019-06-02 00:15 | | Mark Your Calendar For These June PDUFA Dates and more... |
| 2019-06-01 00:15 | | Turning Point sinks on ASCO update for repotrectinib and more... |
